Mangoceuticals (MGRX) Revenue (2023 - 2026)

Mangoceuticals has disclosed Revenue across 4 years of filings, most recently posting $68757.0 for Q2 2026.

• In Q2 2026, Revenue fell 59.1% year-over-year to $68757.0; the TTM figure through Jun 2026 stood at $315227.0 (down 38.91% YoY), while the FY2025 annual figure was $456021.0, down 25.96% from the prior year.
• Revenue came in at $68757.0 for Q2 2026 at Mangoceuticals, up from $67864.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $245160.0 in Q3 2023 to a low of $67864.0 in Q1 2026.
• Average Revenue over 4 years is $138572.0, with a median of $121337.0 recorded in 2024.
• Year-over-year, Revenue soared 112.56% in 2024 and sank 59.1% in 2026.
• Over 4 years, Revenue stood at $244374.0 in 2023, then plunged by 56.93% to $105247.0 in 2024, then slipped by 10.34% to $94360.0 in 2025, then dropped by 27.13% to $68757.0 in 2026.
• Per Business Quant data, the three most recent Revenue figures were $68757.0 in Q2 2026, $67864.0 in Q1 2026, and $94360.0 in Q4 2025.